Flovent HFA 44mcg and/or Equivalents
Flovent HFA 44mcg

Marketed as Flixotide Evohaler 50mcg in the United Kingdom
Manufactured by: Glaxosmithkline
This product is offered for sale by a Licensed Pharmacy located in the United Kingdom
From $0.26 USD/dose
CAN NOT BE SPLIT Must be taken in existing form.
No Generic Alternative Available
No generic alternative is available for this drug.
More Brand Products
Product | Lowest Unit Price |
---|---|
Flovent HFA 44mcg
Marketed as Flovent HFA 50mcg in Canada — Manufactured by: Glaxosmithkline |
$0.36 USD/dose |
Flovent HFA 44mcg
Marketed as Flixotide Inhaler 50mcg in New Zealand — Manufactured by: Glaxosmithkline |
$0.27 USD/dose |
Flovent HFA 44mcg
Marketed as Flixotide Evohaler 50mcg in the United Kingdom — Manufactured by: Glaxosmithkline |
$0.26 USD/dose |
Flovent HFA 44mcg
Marketed as Flixotide Inhaler 50mcg in Australia — Manufactured by: Glaxosmithkline |
$0.28 USD/dose |
Flovent HFA 44mcg
Marketed as Flixotide Evohaler 50mcg in the United Kingdom — Manufactured by: Glaxosmithkline |
$0.26 USD/dose |
No generic alternatives are available for this drug.
Flovent HFA and/or Equivalents warnings, side-effects and general information